• 94
  • 13
  • Favorite

Pfizer To Buy RSV Drug Developer ReViral For Up To $525 Million

Reuters2022-04-07

(Reuters) -Pfizer Inc said on Thursday it would buy privately-held ReViral Ltd in a deal worth as much as $525 million, including milestone payments, to gain access to experimental drugs against the respiratory syncytial virus (RSV).

London-based Reviral has four RSV therapies in its pipeline, with two currently in mid-stage studies, including its lead product candidate sisunatovir.

The deal marks the U.S. drugmaker's second acquisition in less than six months to enhance its drug portfolio. Pfizer acquired Arena Pharmaceuticals in a deal worth $6.7 billion in December, adding a promising bowel disease treatment to its ranks.

RSV is a common respiratory virus that causes symptoms similar to those of a cold. It is a common cause of pneumonia in toddlers and the elderly.

According to analytics firm GlobalData, the RSV prevention market is expected to grow fourteen-fold to $6.3 bln by 2030 from 2020, making it a lucrative market for drugmakers globally.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment13

  • Calvin_GKH
    ·2022-04-08
    Wow
    Reply
    Report
  • wniewnie
    ·2022-04-07
    Nice
    Reply
    Report
  • Tanyl
    ·2022-04-07
    PFE is a good choice to invest
    Reply
    Report
  • dahae
    ·2022-04-07
    A
    Reply
    Report
  • ValuInvestor
    ·2022-04-07
    Ok
    Reply
    Report
  • JL1978
    ·2022-04-07
    Buy buy buy!
    Reply
    Report
  • koolgal
    ·2022-04-07
    Pfizer is on an acquisition spree lately with its latest purchase of ReViral.  Its Covid-19 vaccine is widely used around the world.  Pfizer to the moon! 
    Reply
    Report
  • Aeron2020
    ·2022-04-07
    ok
    Reply
    Report
  • PowerTrade
    ·2022-04-07
    K
    Reply
    Report
  • Ahleepapa
    ·2022-04-07
    SHORT
    Reply
    Report
  • Footixx
    ·2022-04-07
    👍
    Reply
    Report
  • frusty
    ·2022-04-07
    Ok
    Reply
    Report
  • MauChin
    ·2022-04-07
    Thanks for sharing
    Reply
    Report
 
 
 
 

Most Discussed

 
 
 
 
 

7x24

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial